Cardinal Health is in a strong position following the acquisition of the Integrated Oncology Network for $1.115 billion, strategically expanding its presence in the field of oncology. In other recent developments, the company's stock performance has seen some volatility but has presented buying opportunities for investors due to a bullish fiscal outlook. Cardinal Health has also opened a distribution center in Greenville, South Carolina, indicating expansion in its operations. The company has produced strong results for Q3 2024 while also increasing the earnings per share (EPS) guidance for the fiscal year 2024. A deal to acquire Specialty Networks and its PPS Analytics platform has further broadened the company's reach into urology, rheumatology, and gastroenterology. Despite facing some setbacks with regards to OptumRx contracts, the company remains a top value and momentum stock, and investors remain optimistic about its future. The firm's bullish stance is further reinforced by its recent dividend payout and reaffirmed fiscal 2024 non-GAAP EPS guidance. However, as Cardinal Health advances, the loss of OptumRx contracts is an issue worth watching.
Cardinal Health CAH News Analytics from Fri, 03 Nov 2023 07:00:00 GMT to Sun, 22 Sep 2024 10:12:01 GMT -
Rating 7
- Innovation 3
- Information 7
- Rumor 4
